NEW YORK( GenomeWeb) – LifeLabs Medical Laboratory Services today said it is offering NanoString's Prosigna Breast Cancer Prognostic Gene Signature Assay in Canada. 

LifeLabs said it is the first clinical lab in the country to offer the test, which is approved by Health Canada and cleared by the US Food and Drug Administration

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.